NCT00004059View on ClinicalTrials.gov

Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

7-hydroxystaurosporine

DRUG

fluorouracil

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004059 - Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter